Business Achievements

We have developed over 50 different types and more than 4,000 individual monoclonal antibody cell lines to date.
The antibodies we produce are supplied to over 200 immunodiagnostic reagent manufacturers both domestically and internationally, including in South Korea, the United States, Japan, India, and China.